The companies will jointly support a series of educational forums among clinicians beginning later this year highlighting the significant new scientific breakthroughs that are radically transforming the traditional approach to heart disease prevention and prediction
News | Pharmaceuticals
Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
The American College of Cardiology’s Cardiovascular Summit (CV Summit) will take place on February 1-3 in Washington, DC
News | ACC
ACC Cardiovascular Summit Equips CV Team to Transform Care, Address Emerging Trends

January 25, 2024 — The American College of Cardiology’s Cardiovascular Summit (CV Summit) will take place on February 1 ...

Home January 25, 2024
Home
The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias-abnormal heartbeats that start in the heart’s two lower chambers-and an elevated risk of sudden cardiac death in patients with mitral valve disease
Feature
Spotlight on Advancements in Mitral Valve Repair, Research

You may not know Carol Barr, but in the future, she could save your life. Barr’s death at 39 from sudden cardiac arrest ...

Home January 24, 2024
Home
Simona Zannetti, MD, General Manager of its Aortic business for Medtronic
News | Cardiovascular Business
Simona Zannetti, MD, Returns to Lead Medtronic Aortic Business

January 24, 2024 — Medtronic announced the recent appointment of Simona Zannetti, MD, as the General Manager of its ...

Home January 24, 2024
Home
While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil
Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
Category I CPT code for Fractional Flow Reserve derived from computed tomography will provide broader access to HeartFlow’s AI-powered technology, a standard of care for evaluating and treating coronary artery disease
News | CT Angiography (CTA)
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT

January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions ...

Home January 23, 2024
Home
Data from non-randomized cohort confirms dramatic improvement in diuretic response and at least 95% reduction in loop diuretic requirements up to almost four months after last DSR therapy
News | Heart Failure
Sequana Medical Announces DSMB Approval to Start Randomized MOJAVE Cohort

January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home January 23, 2024
Home
The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona
News | AHA
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular ...

Home January 22, 2024
Home
The American College of Cardiology is again urging members of Congress to retroactively eliminate the 3.37% cut to the Medicare Physician Fee Schedule currently in effect and preserve patient access to care
News | Cardiovascular Business
ACC Disappointed by Lack of Medicare Fix in Recent Continuing Resolution

January 22, 2024 — The American College of Cardiology is again urging members of Congress to retroactively eliminate the ...

Home January 22, 2024
Home
The American Heart Association’s 2024 Merit Award winners from Massachusetts, Pennsylvania and California will look at whether chemicals occurring in foods could be used to treat heart disease, try to unravel some of the genomic mysteries of cholesterol and assess how vaping impacts abdominal aortic aneurysms
News | Cardiovascular Business
Three Researchers Awarded $1 million Each to Study New Heart Disease Treatments, Causes

January 22, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods ...

Home January 22, 2024
Home
The American Heart Association’s 2024 Merit Award winners from Massachusetts, Pennsylvania and California will look at whether chemicals occurring in foods could be used to treat heart disease, try to unravel some of the genomic mysteries of cholesterol and assess how vaping impacts abdominal aortic aneurysms
News | Cardiovascular Business
AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)

January 22, 2024 — Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently ...

Home January 22, 2024
Home
Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, which is estimated to be more than 750,000 patients annually worldwide
News | Hypertension
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...

Home January 19, 2024
Home
This study aims to compare the GORE VIABAHN VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this condition
News | Stents
First Patients Enrolled in the Gore VBX Forward Clinical Study

January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX ...

Home January 19, 2024
Home
Sumeet Chugh, MD, shown at work in his Cedars-Sinai laboratory
News | Sudden Cardiac Arrest
Smidt Heart Institute Sudden Cardiac Arrest Expert Receives 2024 Distinguished Scientist Award

January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD, associate director of the Smidt Heart Institute at Cedars-Sinai ...

Home January 19, 2024
Home
Abbott's Volt PFA System is designed to overcome limitations of first-generation PFA systems by providing physicians a clearer indication of contact between the Volt PFA Catheter and targeted tissue
News | Atrial Fibrillation
Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms

January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed ...

Home January 18, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now